Posts Tagged ‘peter reynolds’
The CLEAR Executive Committee
Following recent changes, the CLEAR executive committee is now comprised of the following people.
Andrea Clarke
Membership Manager
Vicky Hodgson
Medicinal Users Panel
Vicky was awarded a fellowship of CLEAR in August 2014
Peter Reynolds
President
Graham Smith
Graham was awarded a fellowship of CLEAR in July 2015
Derek Williams
Derek was awarded a fellowship of CLEAR in February 2014.
He is presently on compassionate leave caring for his mother who is gravely ill.
CLEAR Evidence For the APPG Medicinal Cannabis Inquiry.
Yesterday, 2nd March 2016, Roland Gyallay-Pap and Peter Reynolds were called to give evidence at the All Party Parliamentary Group for Drug Policy Reform Inquiry into Regulation of Cannabis for Medicinal Use.
We have already submitted a 15 page written response. Yesterday’s oral hearing was to enable the inquiry to question us in more detail. We cannot publish our written response or go into great detail about yesterday’s hearing until the inquiry has published its own report which is some weeks away yet.
As we arrived at the hearing, Tom Lloyd, ex-chief constable of Cambridgeshire, was waiting to go in so we sat at the back of the committee room and listened to his contribution. Later, after our session, we adjourned to the Westminster Arms for some legal recreational drug use and to swop notes. Tom is a great asset to the campaign and we were able to update each other on the work we are involved in.

The inquiry panel consisted of three MPs and five members of the House of Lords. Roland opened our session with an account of how cannabis oil had helped in the last months of his mother’s life before she died from pancreatic cancer. The whole panel was visibly moved. Baroness Meacher explained that this was not the only such testimony they had heard. Everyone was extremely receptive. A lot of detailed questions were asked about CLEAR’s work and our knowledge of the science, law and best practice involved in medicinal cannabis.
The inquiry’s report will undoubtedly support some reform of the law around medicinal cannabis. Let us hope it will provoke real action from government.
Talking Cannabis In Parliament.
Today, 8th February 2016, Peter Reynolds, president of CLEAR, met with Norman Lamb MP, Liberal Democrat spokesperson for health, for an update on the cannabis campaign.
Independent Panel of Experts on Cannabis Regulation.
The Liberal Democrats have set up an independent panel of experts to establish how a legalised market for cannabis could work in the United Kingdom. Norman Lamb wants the panel to look at evidence from Colorado, Washington State and Uruguay, where cannabis has been legalised and to make recommendations for the party to consider in the spring.
As a contribution to the panel’s work, CLEAR has provided the independent study it commissioned in 2011, ‘Taxing the UK Cannabis Market’ which establishes the most comprehensive database on the reality of cannabis in the UK. In addition, The CLEAR Plan, ‘How To Regulate Cannabis in Britain’, builds on this data to propose detailed regulations for exactly how the market could work and contribute a £6.7 billion net gain to the UK exchequer.
Imminent Launch of New Medicinal Cannabis Campaign.
Within the next few days, CLEAR, along with other cannabis law reform groups, will co-operate in the launch of probably the largest campaign for access to medicinal cannabis ever seen in the UK. The time has come when people who are suffering must be given the opportunity to stop their pain with a safe, non-toxic, proven alternative to expensive and debilitating pharmaceutical products. The intransigence of successive UK governments must be overcome and this time a strategy is in place which will work.
The CLEAR publication ‘Medicinal Cannabis:The Evidence’ has received international acclaim and is the most comprehensive and up to date review of the scientific evidence supporting the use of cannabis.
Further Development of Liberal Democrat Drugs Policy.
In 1971, when the Misuse of Drugs Act came into force there were approximately 3,000 problematic drug users in the UK. Today, 45 years on, that figure has risen to around 350,000. Norman Lamb describes this as “one of the greatest public policy disasters of all time”. Today, in a speech about the prison service, David Cameron talked of the need to tackle the most difficult social problems facing Britain. Drug crime and drug addiction is probably the single biggest factor in our prison problems and the consequences of 45 years of failed drugs policy pervades our society. As the Liberal Democrats consider this difficult issue, tackling reform of cannabis policy is the first step.
CLEAR, The British Medicinal Cannabis Campaign and UK CBD Combine To Offer Media Briefings.
The subject of cannabis as medicine is certain to rise to the top of the UK news agenda in forthcoming weeks as a new Coronation Street storyline unfolds.
The character Izzy Armstrong (Cherylee Houston) who has Ehlers-Danlos Syndrome, will be seen suffering when her prescription medicine fails to alleviate her pain. Erica Holroyd (Claire King) will then suggest that she starts using cannabis as an alternative and ends up supplying Izzy with the drug. The programme will look at all aspects of the debate on medicinal cannabis and examine the legal implications and the far reaching consequences of Izzy’s actions for her family.
Now, three of the UK’s most important organisations in the field are joining forces to provide the media with facts, evidence and personal testimonies about medicinal cannabis.
CLEAR is the largest drugs policy reform group in the UK with nearly 600,000 followers. The British Medicinal Cannabis Campaign (BMCC) is an independent group consisting of 4,500 members, all of whom are UK-based medicinal cannabis users. UK CBD is the leading distributor of legal, cannabinoid nutraceuticals including the world famous Charlotte’s Web and Mary’s brands.
Roland Gyallay-Pap, managing director of CLEAR, commented:
“Not for the first time, but at a crucial time in the worldwide debate, the issue of medicinal cannabis will be addressed in a British soap. We have high hopes that this will stimulate the debate and bring the absurdity of the UK government’s position into sharp focus.”
Throughout Europe, the USA, Canada, Australia, Israel and South America, interest in and the use of medicinal cannabis is growing fast. The UK is now virtually isolated amongst first world countries with the stubborn refusal of government even to consider the evidence. However there is a growing clamour from politicians, scientists and doctors that it must address what is a deeply cruel and evidence-free policy. Hundreds of thousands already use medicinal cannabis and risk a criminal record just for trying to improve their health. In addition they have to deal with a criminal underworld and risk violence, contaminated and low quality product all because government refuses to take responsibility.
There is now an overwhelming body of peer-reviewed, scientific evidence on the safety and efficacy of cannabis as medicine. CLEAR published ‘Medicinal Cannabis: The Evidence’ in April 2015 which has received international acclaim and is now also available in a Spanish language edition. Download here in English or Spanish.
Individual briefings will be available on request to journalists, reporters, media organisations and other interested parties. Briefings will be led by Peter Reynolds, one of the nation’s leading experts on the science, medicine and politics of cannabis, Mark Scott, a representative of BMCC and Nicolas Ellis, founder and managing director of UK CBD.
Please contact CLEAR to arrange a briefing at your premises by appointment. Alternatively, a central London venue can be arranged on request.
“The British People Have Been Systematically Misled, Misinformed And Deceived About Cannabis.”
Peter Reynolds, president of CLEAR, interviewed on Sky News, Sunday, 9th August 2015
Peter Reynolds Steps Down, Roland Gyallay-Pap Appointed Acting Leader of CLEAR.
At a meeting of the CLEAR Executive Committee held over the weekend of 18th/19th July 2015, Peter Reynolds tendered his resignation as leader. He was first elected as leader in February 2011, won a confidence vote in April 2012 and was re-elected unopposed in February 2014.
Roland-Gyallay-Pap has been appointed acting leader and preparations will now begin for a leadership election.
Roland Gyallay-Pap said:
“I would like to extend a big thank you to Peter for the tireless work he has put in over the past four years. It is through his professionalism and tenacity that CLEAR is where it is now.
“I will seek to capitalise on our achievements so far, extending membership, and further building on the success of our Medicinal Users Panel. Never have we been so close to achieving our goals and I look forward to working with those who share our views on how change can be brought about in the most effective manner.”
Peter Reynolds’ letter of resignation reads:
Dear Colleagues,
This is my resignation from the office of leader of CLEAR, effective immediately.
I will remain a member of the leadership team as president of the executive committee. However, it is time for a new leader to take charge and drive our campaign forward.
I want to thank all members of CLEAR for the opportunity to serve as leader since February 2011. I am immensely proud of what we have achieved. We have built a follower base that exceeds all other UK drugs policy groups combined. We have developed a set of policies and tactics that are more effectively challenging cannabis prohibition than ever before. We have made more progress with government in the last two years than the whole campaign has in the last 50.
I will now concentrate on managing the Medicinal Users Panel. This is at the core of our strategy for practical, achievable law reform. It is, I believe, how I can now make the most effective contribution. CLEAR needs a new face to take the next steps in our campaign and I shall give my full support to our new leader.
Peter Reynolds of CLEAR, Nick Rijke of MS Society. BBC Radio Kent, 8th April 2015
Julia George interviews Peter Reynolds of CLEAR, following publication of the report ‘Medicinal Cannabis:The Evidence’. Nick Rijke, of the MS Society, comments on using cannabis to treat multiple sclerosis and how Sativex, the only licensed cannabis medicine, is very difficult to obtain on prescription.
Medicinal Cannabis:The Evidence.
Today CLEAR publishes ‘Medicinal Cannabis:The Evidence’, a comprehensive and up to date review of the evidence supporting the use of cannabis as medicine.
The report details an extraordinary quantity of peer-reviewed, published evidence that demonstrates the efficacy and safety of using cannabis to treat a wide range of conditions. It looks in detail at five therapeutic areas where the evidence is strongest: Alzheimer’s Disease, Cancer, Chronic Pain, Crohn’s Disease and Multiple Sclerosis.
Archaeological and written evidence suggests mankind has used cannabis for medicinal purposes for as long as 10,000 years. In the 19th century nearly half of all medicines in the British and US pharmacopeia contained cannabis. With the rise of new pharmaceutical medicines it fell into disuse but in 1996 California introduced the first ‘medical marijuana’ laws. Now 210 million people in 34 US states and 250 million people in nine European countries have some form of legal access.
Peter Reynolds, author of the report, said:
“This review finally does away with the myth that there is no proof of the value of medicinal cannabis. There is high quality evidence available from dozens of different sources, including double-blind, placebo-controlled clinical trials. No one who examines the evidence can be in any doubt, any longer. This is a medicine that saves lives and rescues people from pain, suffering and disability with far fewer dangerous and unpleasant side effects than pharmaceutical products. We must move urgently to allow doctors to start prescribing and introduce professional training in the use of cannabis medicines”
The report is available to download from the CLEAR website: http://clear-uk.org/static/media/Reports/medicinal_cannabis-_the_evidence_v1.1.pdf
CLEAR Cannabis Law Reform is the UK’s leading drugs policy reform group with more than 330,000 followers. It aims to end the prohibition of cannabis most urgently for those who need it as medicine. CLEAR also advocates replacing the anarchic mess of prohibition with a framework of regulation which would allow proper control of the product’s strength and quality while providing protection for children and the vulnerable.
CLEAR’s policies are based on independent, expert research carried out by the Independent Drug Monitoring Unit in 2011: http://clear-uk.org/media/uploads/2011/09/TaxUKCan.pdf
CLEAR’s detailed proposals for cannabis regulation, ‘How To Regulate Cannabis In Britain’: http://clear-uk.org/static/media/uploads/2013/10/CLEAR-plan-V2.pdf
CLEAR Medicinal Users Panel. Fifth Delegation To Parliament.

Vicky Hodgson, Kate Stenberg, Roland Gyallay-Pap, Lynne Featherstone MP, Peter Reynolds, Penny Fitzlyon, Richard Tong, Jonathan Liebling
Today a further delegation from CLEAR met with Lynne Featherstone, the new Home Office minister with responsibility for drugs policy. She is the Liberal Democrat MP for Hornsey and Wood Green and was appointed to replace Norman Baker after he resigned in November 2014.
We invited Jonathan Liebling, Political Director of the United Patients Alliance (UPA) to accompany us and he gave eloquent testimony about his own use of medicinal cannabis. UPA has been doing excellent work in running a series of meetings up and down the country bringing medicinal users together. We hope there will be further co-operation between UPA and CLEAR.
Jonathan spoke about using cannabis to help with anxiety and depression, as did Kate Stenberg who has also used cannabis to deal with a chronic pain condition. Vicky Hodgson spoke about treating her scoliosis, COPD and cluster headaches. Roland Gyallay-Pap, related how he produced cannabis oil when his mother was diagnosed with pancreatic cancer and the great help it gave her with sleeping and eating in the final months of her life. Penny Fitzlyon talked about treating her MS with cannabis and how she has now been refused Sativex. It was obvious this had a big impact on the minister.
She listened to each of us very attentively and we all felt that she had taken genuine interest and understood our arguments, particularly about enabling UK patients to import Bedrocan medicinal cannabis.
We also presented Ms Featherstone with a pre-publication copy of the paper ‘Medicinal Cannabis: The Evidence’, which we have produced at the request of George Freeman MP, the Life Sciences minister. This is a literature review of the existing evidence on medicinal cannabis. It makes a powerful argument for the transfer of cannabis from schedule I to schedule II so that it may be prescribed by a doctor. Currently the paper is being peer-reviewed and we hope that it may itself be published in a scientific/medical journal shortly.
CLEAR has also recently delivered a briefing on medicinal cannabis to Nick Clegg, the Deputy Prime Minister and leader of the Liberal Democrats. We shared this with Ms Featherstone as well.
With the General Election fast approaching, all MPs, including minsters, are about to go into campaign mode. Nick Clegg is to cover drugs policy in a speech a Chatham House later this week. There may yet be further developments, specifically on medicinal cannabis as the election campaign unfolds. What is certain is that the new Parliament will represent a real opportunity for change and we have high hopes of real progress.







